• Return to Headlines

Relatively High EBITDA Growth Detected in Shares of Biomarin Pharmac in the Biotechnology Industry (BMRN, MDXG, ALXN, CELG, RGEN)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks highest with a EBITDA growth of 156.0%. Mimedx Group Inc is next with a EBITDA growth of 140.6%. Alexion Pharm ranks third highest with a EBITDA growth of 121.4%.

Celgene Corp follows with a EBITDA growth of 116.7%, and Repligen Corp rounds out the top five with a EBITDA growth of 103.7%.

SmarTrend is tracking the current trend status for Repligen Corp and will alert subscribers who have RGEN in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest ebitda growth biomarin pharmac mimedx group inc alexion pharm celgene corp repligen corp

Ticker(s): BMRN MDXG ALXN CELG RGEN